Abstract
Objective: To assess whether men diagnosed with prostate cancer at younger ages have a poorer prognosis. The influence of select factors (race, marital status, stage, histological grade, histology, presence of comorbid cancer, and time of diagnosis) on the relation between age at diagnosis and survival was considered. Methods: Analyses were based on 289,809 men diagnosed with malignant prostate cancer, ages 40 years and older in the Surveillance, Epidemiology, and End Results (SEER) program between 1973 and 1997, actively followed for vital status through 31 December 1998. Cases diagnosed through autopsy or death certificate were excluded. Five-year relative survival and Cox proportional hazards were used for assessment. Results: Five-year relative survival increased, leveled off, and then decreased over the age span. This pattern was most pronounced in men with advanced stage and poor grade tumors. Conditional death hazards that showed significantly higher hazard ratios in younger age groups (i.e. 40–44 and 45–49) represented local/regional stage and poorly differentiated/undifferentiated tumors, distant stage and moderately differentiated, poorly differentiated/undifferentiated, or unknown grade; and unknown stage and unknown grade. The influence of young age on prostate cancer prognosis for advanced stage and poorly differentiated/undifferentiated cases was not significantly influenced by year of diagnosis or race. Conclusions: Younger age is a prognostic factor for prostate cancer survival. The relationship between young age at diagnosis and survival is significantly influenced by stage and histological grade at diagnosis.
Similar content being viewed by others
References
Belt E, Schro¨ der FH (1972) Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91-96.
Cook GB, Watson FR (1968) A comparison by age of death rates due to prostate cancer alone. J Urol 100: 669-671.
Johnson DE, Lanieri JP, Ayala AG (1972) Prostatic adenocarcinoma occurring in men under 50 years of age. J Surg Oncol 4: 207-216.
Rosenberg SE (1965) Is carcinoma of the prostate less serious in older men? J Am Geriatr Soc 13: 791-798.
Tjaden HB, Culp DA, Flocks RH (1965) Clinical adenocarcinoma of the prostate in patients under 50 years of age. J Urol 93: 618-621.
Wilson JM, Kemp IW, Stein GJ (1984) Cancer of the prostate. Do younger men have a poorer survival rate? Br J Urol 56: 391-396.
Schmidt JD, Welch MJ Jr. (1976) Sarcoma of the prostate. Cancer 37: 1908-1912.
Silber I, McGavran MH (1971) Adenocarcinoma of the prostate in patients less than 56 years old: a study of 65 cases. J Urol 105: 283-285.
Smedley HM, Sinnott M, Freedman LS, Macaskill P, Naylor CPE, Pillers EMK (1983) Age and survival in prostatic carcinoma. Br J Urol 55: 529-533.
Huben R, Natarajan N, Pontes E, Mettlin C, Smart CR, Murphy GP (1982) Carcinoma of the prostate in men less than 50 years old. Data from American College of Surgeons' National Survey. Urology 20: 585-588.
Goodman CM, Busuttil A, Chisholm GD (1988) Age and size and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol 62: 576-580.
Smith CV, Bauer JJ, Connelly RR, et al. (2000) Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164: 1964-1967.
Riopel MA, Polascik TJ, Partin AW, et al. (1995) Radical prostatectomy in men less than 50 years old. Urol Oncol 1: 80-83.
Carter HB, Epstein JI, Partin AW (1999) Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology 53: 126-130.
Ruska KM, Partin AW, Epstein JI (1999) Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings. Urology 53: 1179-1183.
Harrison GS (1983) The prognosis of prostatic cancer in the younger man. Br J Urol 55: 315-320.
Adami HO, Norlen BJ, Malker B, Meirik O (1986) Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. A nation-wide study. Scand J Urol Nephrol 20: 107-112.
Bauer JJ, Connelly RR, Seterhenn IA, et al. (1998) Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. J Urol 159: 929-933.
Benson MC, Kaplan SA, Olsson CA (1987) Prostate cancer in men less than 45 years old. Influence of stage, grade, and therapy. J Urol 137: 888-890.
Gronberg H, Damber J, Jonsson H, Lenner P (1994) Patient age as a prognostic factor in prostate cancer. J Urol 152: 892-895.
Byar DP, Mostofi FK (1969) Cancer of the prostate in men less than 50 years of age: an analysis of 51 cases. J Urol 102: 726-733.
Obek C, Lai S, Sadek S, Civantos F, Soloway MS (1999) Age as a prognostic factor for disease recurrence after radical prostatectomy. Urology 54: 533-538.
Stanford JL, Stephenson RA, Coyle LM, et al. (1999) Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute, Bethesda, MD: National Institutes of Health Publ. No. 99-4543.
Ries LAG, Eisner MP, Kosary CL, et al. (2001) SEER Cancer Statistics Review, 1973-1998. National Cancer Institute. Bethesda, MD: National Institutes of Health.
Hankey BF, Ries LA, Edwards BK (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8: 1117-1121.
Percy C, Van Holten V, Muir C, eds (1990) International Classi-fication of Diseases for Oncology. 2nd edn. Geneva: World Health Organization.
Catalona WT, Bigg SW (1990) Nerve-sparing radical prostetectomy: evaluation of results after 250 patients. J Urol 143: 538-543.
Berg JW (1982) Morphologic classification of human cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. Philadelphia, PA: Saunders, pp. 74-89.
Ries LA, Kosary CL, Lyles BA (1995) Cancer patient survival: why use the relative survival rate. Abstract 21: 28-30.
Henson DE, Ries LA (1995) The relative survival rate. Cancer 76: 1687-1688.
Percy CL, Stanek E III, Gloeckler L (1981) Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71: 242-250.
Percy CL, Miller BA, Ries LA (1990) Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. In: Davis DL, Hoel D, eds. Trends in Cancer Mortality in Industrial Countries. New York: New York Academy of Sciences, pp. 87-99.
Cox DR (1972) Regression models and life-tables. J Royal Stat Soc, Series B 34: 187-220.
Cox DR (1975) Partial likelihood. Biometrika 62: 269-276.
Kalbfleish JD, Prentice RL (1980) The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons.
Parker CC, Gospodarowicz M, Warde P (2001) Does age influence the behaviour of localized prostate cancer? BJU Int 87: 629-637.
Heidenberg HB, Moul JW, Mostofi FK, McLeod DG (1994) Clinically detected carcinoma of the prostate treated by radical prostatectomy in a 29-year old man. J Urol 152: 966-967.
Jadeja NA, Dogra PN, Gupta NP (1994) Carcinoma of the prostate in young patients: a report of two cases. Urol Int 52: 48-51.
Austin JP, Convery K (1993) Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol 16: 140-145. 442 R.M. Merrill and J.S. Bird
Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK (1995) Effect of age and race on the survival of men with cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology 45: 93-101.
Ries L, Fritz A (1998) The SEER Program Code Manual. 3rd edn. Surveillance Program. Bethesda, MD: Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health.
North American Association of Central Cancer Registries (2000) Standards for Cancer Registries. Volume III: Standards for Completeness, Quality, Analysis, and Management of Data.
Feuer EJ, Merrill RM, Hankey BF (1999) Interpreting trends in prostate cancer-Part II: Cause of death misclassification and the recent rise in prostate cancer mortality. J Natl Cancer Inst 91: 1025-1032.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merrill, R.M., Bird, J.S. Effect of young age on prostate cancer survival: a population-based assessment (United States). Cancer Causes Control 13, 435–443 (2002). https://doi.org/10.1023/A:1015764507609
Issue Date:
DOI: https://doi.org/10.1023/A:1015764507609